Neil Senzer
- Oncology top 0.5%
- CAR-T cell therapy research 25
- Cancer Treatment and Pharmacology 23
- Colorectal Cancer Treatments and Studies 13
- Biotechnology top 0.5%
- Cancer Research and Treatments 40
- Otorhinolaryngology top 1%
- Cancer Research top 2%
- Genetics top 1%
- Virus-based gene therapy research 39
-
- RNA Interference and Gene Delivery 23
-
- Immunotherapy and Immune Responses 15
-
- Lung Cancer Treatments and Mutations 15
- Co-authors
- John NemunaitisDonald D. RaoCasey CunninghamManuel HidalgoJohn S. VorhiesPhillip B. MaplesSanjiv S. AgarwalaEverett E. Vokes
- Journals
- Journal of Clinical Oncology (55 papers)Molecular Therapy (12 papers)Cancer Gene Therapy (10 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Neil Senzer
176 papers receiving 7.6k citations
Hit Papers
Peers
Comparison fields: 5 of 138
- Oncology 3.9k
- Biotechnology 793
- Otorhinolaryngology 386
- Cancer Research 1.0k
- Genetics 1.7k
Countries citing papers authored by Neil Senzer
This map shows the geographic impact of Neil Senzer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neil Senzer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neil Senzer more than expected).
Fields of papers citing papers by Neil Senzer
This network shows the impact of papers produced by Neil Senzer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neil Senzer. The network helps show where Neil Senzer may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Neil Senzer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 8 | |
| 2 | 2021 | 26 | |
| 3 | 2018 | 10 | |
| 4 | Assessment of Low Dose Vigil® Engineered Autologous Tumor Cell (EATC) Immunotherapy in Patients with Advanced Solid Tumors | 2017 | 3 |
| 5 | Innovative Exploratory Clinical Approaches for Relapsed and/or Refractory Metastatic Ewing’s Sarcoma | 2016 | 1 |
| 6 | 2016 | 37 | |
| 7 | 2015 | 1 | |
| 8 | 2013 | 53 | |
| 9 | 2011 | 128 | |
| 10 | 2010 | 24 | |
| 11 | 2009 | 75 | |
| 12 | 2009 | 70 | |
| 13 | 2009 | 205 | |
| 14 | 2009 | 116 | |
| 15 | 2008 | 36 | |
| 16 | 2006 | 53 | |
| 17 | 2005 | 143 | |
| 18 | 2003 | 1 | |
| 19 | 2002 | 24 | |
| 20 | 2001 | 9 |
About Neil Senzer
Neil Senzer is a scholar working on Biotechnology, Oncology, Cancer Research, Genetics and Pulmonary and Respiratory Medicine, having authored 176 papers that have together received 7.8k indexed citations. Recurring topics across this work include Cancer Research and Treatments (40 papers), Virus-based gene therapy research (39 papers), CAR-T cell therapy research (25 papers), RNA Interference and Gene Delivery (23 papers), Cancer Treatment and Pharmacology (23 papers), Immunotherapy and Immune Responses (15 papers), Lung Cancer Treatments and Mutations (15 papers) and Colorectal Cancer Treatments and Studies (13 papers). The work is most often cited by research in Oncology (3.9k citations), Biotechnology (793 citations), Otorhinolaryngology (386 citations), Cancer Research (1.0k citations) and Genetics (1.7k citations). Neil Senzer has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include John Nemunaitis, Donald D. Rao, Casey Cunningham, Manuel Hidalgo, John S. Vorhies, Phillip B. Maples, Sanjiv S. Agarwala, Everett E. Vokes, Denis Soulières and Lillian L. Siu. Their work appears in journals such as Journal of Clinical Oncology, Molecular Therapy, Cancer Gene Therapy, Molecular Cancer Therapeutics and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.